title: Effects of m-nisoldipine on aortic calcium accumulation in rats with vascular calcium overload.
abstract: OBJECTIVE
  To study the effects of a novel calcium channel blocker, m-nisoldipine, on vascular calcium overload (VCO) at both tissue and cellular levels.
  
  
  METHODS
  VCO was induced in Wistar rats by treatment with colecalciferol (Col, 400,000 IU.kg-1, p.o.) and an aqueous mixture of ethanol and polyethyleneglycol-400 for 3 d. The tissue and subcellular calcium contents of aorta were determined by atomic absorption spectrometer and electron probe microanalysis, respectively.
  
  
  RESULTS
  Chronic treatment with m-nisoldipine (m-Nis, 1-15 mg.kg-1, p.o., bid) only had mild inhibition on the elevation of total calcium in aorta, and the dose-response relationship of m-Nis displayed a bell shape, with inhibition ratio of 24% only for m-Nis 2.5 mg.kg-1. The effect of verapamil (12.5 mg.kg-1, p.o., bid) was a little better than that of m-Nis. The intracellular VCO in medial smooth muscle cells of aorta were remarkably inhibited by m-Nis (2.5 mg.kg-1), with inhibition ratios of 72% for cytoplasm and 76% for mitochondrion. The calcium accumulation in nucleus was reduced to a lesser degree than those in cytoplasm and mitochondrion.
  
  
  CONCLUSIONS
  As for aorta in VCO rats, m-Nis mainly had conspicuous inhibition on intracellular VCO in medial smooth muscle cells, particularly in cytoplasm and mitochondrion, but with little effect on extracellular calcium deposition at tissue level.
authors.affiliation: Department of Pharmacology, Shanghai Medical University, China.
authors.forename: A Y
authors.initials: AY
authors.lastname: Sun
authors.forename: Z C
authors.initials: ZC
authors.lastname: Yang
authors.forename: C S
authors.initials: CS
authors.lastname: Zhong
authors.forename: M H
authors.initials: MH
authors.lastname: Jiang
authors.forename: Z
authors.initials: Z
authors.lastname: Yu
authors.forename: Y M
authors.initials: YM
authors.lastname: Wang
mesh_terms: D000818:Animals; D001013:Aorta, Thoracic / Q000378:metabolism*; D002118:Calcium / Q000378:metabolism*; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D066298:In Vitro Techniques; D008297:Male; D008931:Mitochondria, Muscle / Q000378:metabolism; D009131:Muscle, Smooth, Vascular / Q000378:metabolism; D015737:Nisoldipine / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar
chemical_list: D002121:Calcium Channel Blockers; D015737:Nisoldipine; D002118:Calcium